Measuring medicine: How new technologies could help doctors predict patien...(movement of water within body tissue. It...),Health
movement of water within body tissue. It is commonly used to evaluate brain injury in stroke patients, and is gaining clinical popularity as a method for distinguishing different types of tissues or tumors.
In this study, researchers assessed brain tumor response by diffusion MRI in 60 patients with high grade glioma who were undergoing radiation therapy. The patients were assessed at one, three and 10 weeks after the start of radiation treatment. Researchers found measurable changes in diffusion MRI as assessed by fDM as early as the first week of treatment. Assessment at week three of therapy was a strong predictor of survival at one year. The strongest predictor was a combination of diffusion MRI and conventional MRI at week 10.
Ross says diffusion MRI is a better predictor of outcome at early stages of disease because it measures changes in cellular density. Researchers believe that a tumor responding to treatment will show decreased cell density, and, as a result, surrounding water will move more freely. Diffusion MRI enables physicians to see this water movement almost immediately instead of waiting the eight to 10 weeks traditionally needed to see if a particular treatment, such as radiation therapy, has shrunk a tumor, or if the tumor has grown.
This is a more accurate measure of tumor response than simply measuring the size of the tumor. Tumors may appear to get larger or have more contrast enhancement as a response to therapy even if the tumor is not actually growing, said Ross. Diffusion MRI may help differentiate which patients are doing well even if the tumor grows.
Presence of amphiregulin autocrine-loop predicts sensitivity of EGFR wild type cancers to gefitinib and cetuximab: Abstract 4958
Researchers have discovered a biomarker in epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC) cell lines. This so-called
'/>"/>
| Contact: Staci Vernick Goldberg Staci.goldberg@aacr.org 267-646-0616 American Association for Cancer Research Source:Eurekalert |
Related medicine news :
1. MEDIA ALERT: Eularis to Address Marketing Return at Measuring Marketing ROI in Pharma Conference in London
2. PET Scans Best for Measuring Response to Sarcoma Treatment
3. PDSS reliable in measuring impact of sleep disorders on teens academic performance
4. Mastering Challenges & Measuring Successes for Quality Initiatives in Sales, Marketing and Product Development
5. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
6. Study says COPD testing is not measuring up
7. The Changing Face of Medicine: National Medical Fellowships Annual Awards Gala Honors Three Fellows
8. Breakaway Technologies Celebrates 10 Years in Business
9. Intronis Technologies eSureIT Partner Program Certified Gold By CMP Channels VARBusiness
10. Greenway Medical Technologies Experiences Continued Growth in OB/GYN Marketplace
11. China Medical Technologies to Announce 4QFY2007 Financial Results, Declare Annual Cash Dividend and Provide FY2008 Annual Targets on June 12, 2008
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |